Back
Smith & Nephew PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
39
SNNUF
Smith & Nephew PLC
Last Price:
12.33
Seasonality Move:
1.11%
Sell
39
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.21
Seasonality Move:
-0.77%
Sell
39
Smith & Nephew PLC (SNNUF)
is a Sell
Is Smith & Nephew PLC a Buy, Sell or Hold?
- The current Smith & Nephew PLC [SNNUF] share price is $12.33. The Score for SNNUF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- SNNUF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.20. The Score for ADAP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNNUF Stock Price Chart
What is Smith & Nephew PLC's stock price today?
-
The Smith & Nephew PLC share price today is $12.33
The current trend is relatively stagnant and SNNUF is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.20
The current trend is relatively stagnant and ADAP is experiencing slight selling pressure.
SNNUF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 51.03 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.85 - 12.37) | Buy |
| Bollinger Bands (100): | (12.47 - 13.93) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 50.13 | Buy |
| Chaikin Money Flow: | -100608 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.03 - 1.41) | Sell |
| Bollinger Bands (100): | (0.73 - 1.47) | Buy |
SNNUF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.05 | Buy |
| 20-day SMA: | 12.06 | Buy |
| 50-day SMA: | 12.82 | Sell |
| 200-day SMA: | 13.04 | Sell |
| 8-day EMA: | 12.12 | Buy |
| 20-day EMA: | 12.18 | Buy |
| 50-day EMA: | 12.59 | Sell |
| 200-day EMA: | 13.16 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.11 | Buy |
| 20-day SMA: | 1.15 | Buy |
| 50-day SMA: | 1.37 | Sell |
| 200-day SMA: | 0.9 | Buy |
| 8-day EMA: | 1.13 | Buy |
| 20-day EMA: | 1.17 | Buy |
| 50-day EMA: | 1.22 | Sell |
| 200-day EMA: | 1.08 | Buy |
Smith & Nephew PLC Earnings Growth & SNNUF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.08 per share.
Smith & Nephew PLC Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||